Impax Labs (IPXL), Zogenix (ZGNX) Rise as FDA Won't Block Generic Opana (ENDP)
Tweet
Share
E-mailGet Alerts IPXL Hot Sheet
Join SI Premium – FREE
Impax Labs, Inc. (NASDAQ: IPXL) and Zogenix (Nasdaq: ZGNX) are active as the FDA denied a petition to block generic forms of Endo Pharma's (Nasdaq: ENDP) Opana.
Create E-mail Alert Related Categories
FDA, Insiders' Blog, Momentum MoversSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
